메뉴 건너뛰기




Volumn 98, Issue 4, 2006, Pages 447-452

Outcome of Percutaneous Coronary Intervention in Unstable Angina Pectoris Versus Stable Angina Pectoris in Two Different Time Periods

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIAC PATIENT; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DEATH; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REGISTER; REVASCULARIZATION; RISK ASSESSMENT; RISK FACTOR; STABLE ANGINA PECTORIS; STATISTICAL SIGNIFICANCE; TIME; UNSTABLE ANGINA PECTORIS;

EID: 33746729443     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.03.021     Document Type: Article
Times cited : (10)

References (17)
  • 1
    • 0034642318 scopus 로고    scopus 로고
    • Percutaneous coronary intervention in the current era compared with 1985-1986. the National Heart, Lung, and Blood Institute Registries
    • Coinvestigators
    • Williams D.O., Holubkov R., Yeh W., Bourassa M.G., Al-Bassam M., Block P.C., Coady P., Cohen H., Cowley M., Dorros G., et al., Coinvestigators. Percutaneous coronary intervention in the current era compared with 1985-1986. the National Heart, Lung, and Blood Institute Registries. Circulation 102 (2000) 2945-2951
    • (2000) Circulation , vol.102 , pp. 2945-2951
    • Williams, D.O.1    Holubkov, R.2    Yeh, W.3    Bourassa, M.G.4    Al-Bassam, M.5    Block, P.C.6    Coady, P.7    Cohen, H.8    Cowley, M.9    Dorros, G.10
  • 4
    • 11144355354 scopus 로고    scopus 로고
    • Intensive versus moderate lipid lowering with statins after acute coronary syndromes
    • Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators
    • Cannon C.P., Braunwald E., McCabe C.H., Rader D.J., Rouleau J.L., Belder R., Joyal S.V., Hill K.A., Pfeffer M.A., Skene A.M., and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350 (2004) 1495-1504
    • (2004) N Engl J Med , vol.350 , pp. 1495-1504
    • Cannon, C.P.1    Braunwald, E.2    McCabe, C.H.3    Rader, D.J.4    Rouleau, J.L.5    Belder, R.6    Joyal, S.V.7    Hill, K.A.8    Pfeffer, M.A.9    Skene, A.M.10
  • 5
    • 0035908781 scopus 로고    scopus 로고
    • Effects of pretreatment with clopidogrel and aspirin followed by lont-term therapy in patients undergoing percutaneous coronary intervention. the PCI-CURE study
    • Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators
    • Mehta S.R., Yusuf S., Peters R.J.G., Bertrand M.E., Lewis B.S., Natarajan M.K., Malmberg K., Rupprecht H., Zhao F., Chrolavicius S., et al., Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators. Effects of pretreatment with clopidogrel and aspirin followed by lont-term therapy in patients undergoing percutaneous coronary intervention. the PCI-CURE study. Lancet 358 (2001) 527-533
    • (2001) Lancet , vol.358 , pp. 527-533
    • Mehta, S.R.1    Yusuf, S.2    Peters, R.J.G.3    Bertrand, M.E.4    Lewis, B.S.5    Natarajan, M.K.6    Malmberg, K.7    Rupprecht, H.8    Zhao, F.9    Chrolavicius, S.10
  • 6
    • 0037145863 scopus 로고    scopus 로고
    • Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention. a randomized controlled trial
    • CREDO Investigators
    • Steinhubl S.R., Berger P.B., Mann III J.T., Fry E.T., DeLago A., Wilmer C., Topol E.J., and CREDO Investigators. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention. a randomized controlled trial. JAMA 288 (2002) 2411-2420
    • (2002) JAMA , vol.288 , pp. 2411-2420
    • Steinhubl, S.R.1    Berger, P.B.2    Mann III, J.T.3    Fry, E.T.4    DeLago, A.5    Wilmer, C.6    Topol, E.J.7
  • 8
    • 0027934377 scopus 로고
    • A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease
    • Stent Restenosis Study Investigators
    • Fischman D.L., Leon M.B., Baim D.S., Schatz R.A., Savage M.P., Penn I., Detre K., Veltri L., Ricci D., Nobuyoshi M., et al., Stent Restenosis Study Investigators. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 331 (1994) 496-501
    • (1994) N Engl J Med , vol.331 , pp. 496-501
    • Fischman, D.L.1    Leon, M.B.2    Baim, D.S.3    Schatz, R.A.4    Savage, M.P.5    Penn, I.6    Detre, K.7    Veltri, L.8    Ricci, D.9    Nobuyoshi, M.10
  • 9
    • 2642599026 scopus 로고    scopus 로고
    • Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction
    • The Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Angina and Symptoms (PRISM-PLUS) Study Investigators
    • The Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Angina and Symptoms (PRISM-PLUS) Study Investigators. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. N Engl J Med 338 (1998) 1488-1497
    • (1998) N Engl J Med , vol.338 , pp. 1488-1497
  • 10
    • 2642654221 scopus 로고    scopus 로고
    • A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina
    • The Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators
    • The Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. N Engl J Med 338 (1998) 1498-1505
    • (1998) N Engl J Med , vol.338 , pp. 1498-1505
  • 11
    • 0008926519 scopus 로고    scopus 로고
    • Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes
    • The PURSUIT Trial Investigators
    • The PURSUIT Trial Investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med 339 (1998) 436-443
    • (1998) N Engl J Med , vol.339 , pp. 436-443
  • 13
    • 0028297522 scopus 로고
    • Relation between procedural activated coagulation time and outcome after percutaneous transluminal coronary angioplasty
    • Ferguson J.J., Dougherty K.G., Gaos C.M., Bush H.S., Marsh K.C., and Leachman D.R. Relation between procedural activated coagulation time and outcome after percutaneous transluminal coronary angioplasty. J Am Coll Cardiol 23 (1994) 1061-1065
    • (1994) J Am Coll Cardiol , vol.23 , pp. 1061-1065
    • Ferguson, J.J.1    Dougherty, K.G.2    Gaos, C.M.3    Bush, H.S.4    Marsh, K.C.5    Leachman, D.R.6
  • 14
    • 0035875789 scopus 로고    scopus 로고
    • ACC/AHA guidelines for percutaneous coronary intervention: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty)
    • Smith Jr. S.C., Dove J.T., Jacobs A.K., Kennedy J.W., Kereiakes D., Kern M.J., Kuntz R.E., Popma J.J., Schaff H.V., Williams D.O., et al. ACC/AHA guidelines for percutaneous coronary intervention: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1993 Guidelines for Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol 37 (2001) 2215-2238
    • (2001) J Am Coll Cardiol , vol.37 , pp. 2215-2238
    • Smith Jr., S.C.1    Dove, J.T.2    Jacobs, A.K.3    Kennedy, J.W.4    Kereiakes, D.5    Kern, M.J.6    Kuntz, R.E.7    Popma, J.J.8    Schaff, H.V.9    Williams, D.O.10
  • 15
    • 20844462894 scopus 로고    scopus 로고
    • Beneficial effects of fluvastatin following percutaneous coronary intervention in patients with unstable and stable angina. results from the Lescol Intervention Prevention Study (LIPS)
    • Lee C.H., de Feyter P., Serruys P.W., Saia F., Lemos P.A., Goedhardt D., Soares P.R., Umans V.A.E.M., Ciccone M., and Corellaro M. Beneficial effects of fluvastatin following percutaneous coronary intervention in patients with unstable and stable angina. results from the Lescol Intervention Prevention Study (LIPS). Heart 90 (2004) 1156-1161
    • (2004) Heart , vol.90 , pp. 1156-1161
    • Lee, C.H.1    de Feyter, P.2    Serruys, P.W.3    Saia, F.4    Lemos, P.A.5    Goedhardt, D.6    Soares, P.R.7    Umans, V.A.E.M.8    Ciccone, M.9    Corellaro, M.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.